Ajuntament De L Hospitalet De Llobregat
- Address
- lock Available on a paid plan
Neoplasms Research at Ajuntament De L Hospitalet De Llobregat
The Medical Oncology department is focused on neoplasms, with trials centered on improving care for patients with carcinoma and glioblastoma. This research aims to evaluate new treatment approaches and better understand how combined cancer therapies may support outcomes in difficult-to-treat tumors.
- Studies in head and neck squamous cell carcinoma are assessing whether new immunotherapy and targeted treatment combinations can improve disease control alongside radiotherapy.
- Research in glioblastoma is exploring the safety and potential benefit of adding novel supportive treatment strategies to standard care for newly diagnosed patients.
At this hospital in L'hospitalet De Llobregat, the clinical program is small but highly specialized, with work aimed at testing whether new cancer treatment combinations can improve effectiveness in challenging oncology settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ajuntament De L Hospitalet De Llobregat
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase 2 trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection | NHS Tayside, University Of Dundee | Phase II | Not Recruiting | Nov 2023 | Jul 2024 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dostarlimab | 1 | Unknown | 2023-11-08 | 2023-11-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.